MDXG
Price:
$3.6
Market Cap:
$536.20M
MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial for manufacturing allografts that preserve the natural biological characteristics and essential regulatory proteins of the original tissue. This exclusive and patented processing technique incorporates both aseptic procedures and a final sterilization step, ensuring product safety and efficacy. Among its offerings is EpiFix, a semi-permeable membrane designed to act as a protective barrier, effectively treating persistent wounds such as diabetic f...[Read more]
Industry
Biotechnology
IPO Date
2008-02-12
Stock Exchange
NASDAQ
Ticker
MDXG
According to MiMedx Group, Inc.’s latest financial reports and current stock price. The company's current ROE is 12.86%. This represents a change of 298.65% compared to the average of 3.22% of the last 4 quarters.
The mean historical ROE of MiMedx Group, Inc. over the last ten years is -5.76%. The current 12.86% ROE has changed -323.19% with respect to the historical average. Over the past ten years (40 quarters), MDXG's ROE was at its highest in in the September 2023 quarter at 641.65%. The ROE was at its lowest in in the December 2018 quarter at -72.95%.
Average
-5.76%
Median
-2.14%
Minimum
-74.36%
Maximum
87.71%
Discovering the peaks and valleys of MiMedx Group, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 874.22%
Maximum Annual ROE = 87.71%
Minimum Annual Increase = -216.59%
Minimum Annual ROE = -74.36%
| Year | ROE | Change |
|---|---|---|
| 2025 | 18.94% | -13.80% |
| 2024 | 21.97% | -53.51% |
| 2023 | 47.25% | -216.59% |
| 2022 | -40.53% | 205.02% |
| 2021 | -13.29% | -75.35% |
| 2020 | -53.91% | -27.51% |
| 2019 | -74.36% | 23.17% |
| 2018 | -60.37% | -168.83% |
| 2017 | 87.71% | 874.22% |
| 2016 | 9.00% | -66.98% |
The current ROE of MiMedx Group, Inc. (MDXG) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
29.39%
5-year avg
6.87%
10-year avg
-5.76%
MiMedx Group, Inc.’s ROE is less than Innoviva, Inc. (47.59%), greater than Sana Biotechnology, Inc. (-161.87%), greater than Dianthus Therapeutics, Inc. (-1.78%), greater than Nektar Therapeutics (-87.00%), greater than Atai Beckley Inc. (-366.49%), greater than Rapport Therapeutics, Inc. Common Stock (-24.79%), greater than Taysha Gene Therapies, Inc. (-56.07%), greater than Inhibrx Biosciences, Inc. (-563.89%), greater than Syndax Pharmaceuticals, Inc. (-256.66%), less than CureVac N.V. (18.40%),
| Company | ROE | Market cap |
|---|---|---|
| 47.59% | $1.68B | |
| -161.87% | $745.82M | |
| -1.78% | $3.43B | |
| -87.00% | $1.16B | |
| -366.49% | $1.44B | |
| -24.79% | $1.40B | |
| -56.07% | $1.43B | |
| -563.89% | $1.35B | |
| -256.66% | $1.62B | |
| 18.40% | $1.05B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MiMedx Group, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MiMedx Group, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is MiMedx Group, Inc.'s ROE?
How is the ROE calculated for MiMedx Group, Inc. (MDXG)?
What is the highest ROE for MiMedx Group, Inc. (MDXG)?
What is the 3-year average ROE for MiMedx Group, Inc. (MDXG)?
What is the 5-year average ROE for MiMedx Group, Inc. (MDXG)?
How does the current ROE for MiMedx Group, Inc. (MDXG) compare to its historical average?